首页> 外文期刊>Oncology reports >Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer
【24h】

Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer

机译:从未出现在有丝分裂基因A相关激酶6和极光激酶A:从溃疡性结肠炎到结直肠癌的转换中的新基因生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Ulcerative colitis (UC) is an important risk factor for colorectal cancer (CRC). Histone modifications are one of the epigenetic mechanisms that may have key roles in the carcinogenesis of CRC. At present, there are no studies comparing histone modification patterns of UC and CRC in the literature. Therefore the aim of the present study was to investigate whether genes, particularly those involved in histone modification, have value in patient monitoring with regards to CRC development in UC. Key gene expressions of the histone modification enzyme were assessed and compared in CRC, UC and control groups using the RT-PCR array technique. Patients were divided into subgroups based on the extent and duration of the disease and inflammatory burden, which are considered risk factors for CRC development in UC patients. In UC and CRC groups, a significantly higher overexpression of the NEK6 and AURKA genes compared to the control group was identified. In addition, there was a significantly higher overexpression of HDAC1 and PAK1 genes in the UC group, and of HDAC1, HDAC7, PAKI and AURKB genes in the CRC group. NEK6, AURKA, HDAC1 and PAK1 were significantly overexpressed in patients with a longer UC duration. Overexpression of AURKA and NEK6 genes was significantly more pronounced in UC patients with more extensive colon involvement. HDAC1, HDAC7, PAK1, NEK6, AURKA and AURKB are important diagnostic and prognostic markers involved in the carcinogenesis of CRC. HDAC1, PAK1, NEK6 and AURKA may be considered as diagnostic markers to be used in CRC screening for UC patients.
机译:溃疡性结肠炎(UC)是结直肠癌(CRC)的重要危险因素。组蛋白修饰是表观遗传机制之一,可能在CRC的致癌作用中起关键作用。目前,尚无研究比较UC和CRC的组蛋白修饰方式。因此,本研究的目的是调查基因,尤其是涉及组蛋白修饰的基因,是否在患者监测方面具有关于CRC在UC中发展的价值。使用RT-PCR阵列技术评估组蛋白修饰酶的关键基因表达,并在CRC,UC和对照组中进行比较。根据疾病的程度和持续时间以及炎性负担将患者分为亚组,这被认为是UC患者发生CRC的危险因素。在UC和CRC组中,与对照组相比,NEK6和AURKA基因的过表达明显更高。此外,UC组中HDAC1和PAK1基因的过表达明显更高,而CRC组中HDAC1,HDAC7,PAKI和AURKB基因的过表达则更高。 UC持续时间较长的患者中,NEK6,AURKA,HDAC1和PAK1明显过表达。 AURKA和NEK6基因的过表达在结肠广泛参与的UC患者中更为明显。 HDAC1,HDAC7,PAK1,NEK6,AURKA和AURKB是涉及CRC致癌作用的重要诊断和预后标志物。 HDAC1,PAK1,NEK6和AURKA可能被视为诊断标记,可用于UC患者的CRC筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号